Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review by Xin Fei, Zhong Zheng, Zhen-ya Zhao, Da-wei Ren, Su-ying Wang, Shi-jie Ye, Lin-chun Liang, Da Li, Da Li, Xiao-long Jia, Qi Ma, Qi Ma

Get full text